Evaluation of retinotoxicity of COVID-19 treatment: Hydroxychloroquine and lopinavir/ritonavir

J Med Virol. 2021 Feb;93(2):644-646. doi: 10.1002/jmv.26420. Epub 2020 Sep 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antimalarials / adverse effects
  • Antiviral Agents / adverse effects*
  • COVID-19 / complications
  • COVID-19 Drug Treatment*
  • Cross-Sectional Studies
  • Drug Combinations
  • Female
  • Humans
  • Hydroxychloroquine / adverse effects*
  • Lopinavir / adverse effects*
  • Male
  • Middle Aged
  • Optical Imaging
  • Retina / diagnostic imaging
  • Retina / drug effects*
  • Retina / pathology
  • Retina / virology
  • Ritonavir / adverse effects*
  • Tomography, Optical Coherence

Substances

  • Antimalarials
  • Antiviral Agents
  • Drug Combinations
  • lopinavir-ritonavir drug combination
  • Lopinavir
  • Hydroxychloroquine
  • Ritonavir